MMEN — Medmen Enterprises Income Statement
0.000.00%
Last trade - 00:00
Consumer CyclicalsSpeculativeMicro Cap
R2018 June 30th | C2019 June 29th | R2020 June 27th | R2021 June 26th | 2022 June 25th | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 52 W | 52 W | 52 W |
Source: | ARS | ARS/A | ARS | ARS | ARS |
Standards: | IFRS | USG | USG | USG | USG |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 39.8 | 120 | 155 | 132 | 141 |
Cost of Revenue | |||||
Gross Profit | 13.1 | 55.5 | 55.4 | 60.7 | 69.7 |
Selling / General / Administrative Expenses | |||||
Depreciation and Amortization | |||||
Unusual Expense / Income | |||||
Other Operating Expenses | |||||
Total Operating Expenses | 151 | 371 | 631 | 203 | 299 |
Operating Profit | -111 | -251 | -476 | -71.2 | -159 |
Total Net Non Operating Interest Income / Expense | |||||
Net Income Before Taxes | -111 | -263 | -498 | -122 | -175 |
Provision for Income Taxes | |||||
Net Income After Taxes | -114 | -257 | -457 | -124 | -166 |
Minority Interest | |||||
Net Income Before Extraordinary Items | |||||
Extraordinary Items | |||||
Net Income | -67.6 | -69.1 | -247 | -124 | -195 |
Adjustments to Net Income | |||||
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Diluted Net Income | -67.6 | -69.1 | -247 | -131 | -195 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | -1.67 | -0.532 | 0.02 | -0.188 | -0.077 |